Product Information
PHENTERMINE 37.5 MG CAPSULE is a generic product labeled by KVK-Tech Inc., priced at $0.0952 per EA under NDC 10702002903. Its NADAC has been published 294 times since Nov 11, 2020.
Strength
37.5 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702002903
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040887On Market Since
8/15/2012
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG CAPSULE has been published 294 times since Nov 11, 2020, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0952 per EA |
|---|---|
| All-time high | $0.1421 (Apr 10, 2024) |
| All-time low | $0.0688 (Dec 23, 2020) |
| 52-week high | $0.1056 |
| 52-week low | $0.0794 |
| Median price | $0.0961 |
| Average price | $0.0983 |
| Largest weekly change | +64.3% (Nov 22, 2023) |
| Weeks tracked | 294 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG CAPSULE, manufactured by KVK-Tech Inc., is $0.0952 per EA (NDC 10702002903), effective Jun 24, 2026.
How has the price of PHENTERMINE 37.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG CAPSULE has declined 18.2%. It has been tracked across 294 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG CAPSULE?
Since Nov 11, 2020, the NADAC for PHENTERMINE 37.5 MG CAPSULE has ranged from a low of $0.0688 (Dec 23, 2020) to a high of $0.1421 (Apr 10, 2024), with a median of $0.0961 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 37.5 MG TABLET, is $0.0697 per EA — about 27% below PHENTERMINE 37.5 MG CAPSULE.
Who manufactures PHENTERMINE 37.5 MG CAPSULE?
PHENTERMINE 37.5 MG CAPSULE (NDC 10702002903) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification